Clinical trial
Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell…
NCT00006695 · University of Nebraska, Other · Completed
Key facts
| NCT number | NCT00006695 |
|---|---|
| Title | Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's Lymphoma |
| Official title | BEAM Plus Iodine-131 Anti-B1 Antibody and Autologous Hematopoietic Stem Cell Transplantation for Treatment of Recurrent Diffuse Large B-Cell Non-Hodgkin's Lymphoma |
| Lead sponsor | University of Nebraska, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | carmustine, cytarabine, etoposide, melphalan, peripheral blood stem cell transplantation, tositumomab and iodine I 131 tositumomab |
| Enrollment | 50 |
| Start date | Apr 1, 2000 |
| Primary completion | Sep 1, 2005 |
| Completion | Dec 16, 2014 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 1, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: